Skip to main content

Kamin Peter's Form 4 filing

Psychemedics Corp (PMD) · filed Apr 21, 2022

Accession no.
0000921895-22-001329
Filed
Apr 21, 2022
Trade date
Apr 19-20, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market purchases total $284.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kamin PeterCIK 000093754110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 19, 2022Common StockPPurchaseAcquired+11,706$6.52F1+$76,323.12216,778Indirect
Apr 19, 2022Common StockPPurchaseAcquired+15,152$6.52F1+$98,791.04143,190Indirect
Apr 19, 2022Common StockPPurchaseAcquired+627$6.52F1+$4,088.0443,180Indirect
Apr 20, 2022Common StockPPurchaseAcquired+8,100$6.72F5+$54,432214,031Direct
Apr 20, 2022Common StockPPurchaseAcquired+1,950$6.72F5+$13,104218,728Indirect
Apr 20, 2022Common StockPPurchaseAcquired+3,808$6.72F5+$25,589.76146,998Indirect
Apr 20, 2022Common StockPPurchaseAcquired+1,800$6.72F5+$12,09644,980Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.25 to $6.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 3 transactions in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.57 to $6.80 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 4 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)